Racial/ethnic differences in 21-gene recurrence score and survival among estrogen receptor-positive breast cancer patients.

被引：0
|
作者：
Gill, Jasmin
Ma, Sung Jun
Yendamuri, Keerti
Chatterjee, Udit
Yao, Song
Oladeru, Oluwadamilola Temilade
Singh, Anurag K.
机构：
[1] SUNY Buffalo, Buffalo, NY USA
[2] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
[3] Univ Florida COM, Gainesville, FL USA
[4] Roswell Pk Canc Inst, Dept Canc Prevent & Populat Sci, Buffalo, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
511
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Association of Body Mass Index With 21-Gene Recurrence Score Among Women With Estrogen Receptor-Positive, ERBB2-Negative Breast Cancer
    Lee, Janghee
    Kim, Hakyoung
    Bae, Soong June
    Ji, Jung Hwan
    Lee, Jong Won
    Son, Byung Ho
    Ahn, Sei Hyun
    Jeong, Joon
    Lee, Sae Byul
    Ahn, Sung Gwe
    JAMA NETWORK OPEN, 2022, 5 (11) : E2243935
  • [32] Predictive and Prognostic Value of the 21-Gene Recurrence Score in Hormone Receptor-positive, Node-positive Breast Cancer
    Brufsky, Adam M.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (04): : 404 - 410
  • [33] Distribution patterns of 21-gene recurrence score in 980 Chinese estrogen receptor-positive, HER2-negative early breast cancer patients
    Wu Jiayi
    Fang Yan
    Lin Lin
    Fei Xiaochun
    Gao Weiqi
    Zhu Siji
    Zong Yu
    Chen Xiaosong
    Huang Ou
    He Jianrong
    Zhu Li
    Chen Weiguo
    Li Yafen
    Shen Kunwei
    ONCOTARGET, 2017, 8 (24) : 38706 - 38716
  • [34] Racial Differences in 21-Gene Recurrence Scores Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer (vol 36, pg 652, 2018)
    Holowatyj, A. N.
    Cote, M. L.
    Ruterbusch, J. J.
    Ghanem, K.
    Schwartz, A. G.
    Vigneau, F. D.
    Gorski, D. H.
    Purrington, K. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (10) : 1054 - 1054
  • [35] The Clinical Impact of 21-Gene Recurrence Score on Treatment Decisions for Patients with Hormone Receptor-Positive Early Breast Cancer in Korea
    Lee, Moo Hyun
    Han, Wonshik
    Lee, Jeong Eon
    Kim, Ku Sang
    Park, Heeseung
    Kim, Jongjin
    Bae, Soo Youn
    Shin, Hyun Joo
    Lee, Jong Won
    Lee, Eun Sook
    CANCER RESEARCH AND TREATMENT, 2015, 47 (02): : 208 - 214
  • [36] Physician Survey of the Effect of the 21-Gene Recurrence Score Assay Results on Treatment Recommendations for Patients With Lymph Node-Positive, Estrogen Receptor-Positive Breast Cancer
    Oratz, Ruth
    Kim, Benjamin
    Chao, Calvin
    Skrzypczak, Stanley
    Ory, Caron
    Bugarini, Roberto
    Broder, Michael
    JOURNAL OF ONCOLOGY PRACTICE, 2011, 7 (02) : 94 - +
  • [37] Association Between the 21-Gene Recurrence Score and Isolated Local-Regional Recurrence in Hormone Receptor-Positive Breast Cancer
    Buscariollo, D.
    Cronin, A.
    Bleicher, R. J.
    Cohen, A.
    Hassett, M. J.
    Javid, S.
    Kumar, S.
    Moy, B.
    Niland, J.
    Wolff, A.
    Punglia, R. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E13 - E13
  • [38] Predictive value of 21-gene recurrence score assay in non-estrogen receptor-positive and lymph node-negative breast cancer
    Lu, Kai
    Li, Hui
    Wu, Zhaoshu
    Liu, Dong
    Ye, Hongling
    Xu, Liang
    Liu, Yanwen
    JOURNAL OF BUON, 2018, 23 (05): : 1297 - 1301
  • [39] Evaluating the 21-gene assay Recurrence Score® as a predictor of clinical response to 24 weeks of neoadjuvant exemestane in estrogen receptor-positive breast cancer
    Takayuki Ueno
    Norikazu Masuda
    Takeharu Yamanaka
    Shigehira Saji
    Katsumasa Kuroi
    Nobuaki Sato
    Hiroyuki Takei
    Yutaka Yamamoto
    Shinji Ohno
    Hiroko Yamashita
    Kazufumi Hisamatsu
    Kenjiro Aogi
    Hiroji Iwata
    Hironobu Sasano
    Masakazu Toi
    International Journal of Clinical Oncology, 2014, 19 : 607 - 613
  • [40] Clinical analysis of 21-gene recurrence score test in hormone receptor-positive early-stage breast cancer
    Zhu, Lizhe
    Ma, Nan
    Wang, Bin
    Zhou, Can
    Yan, Yu
    Wang, Ke
    He, Jianjun
    Ren, Yu
    ONCOLOGY LETTERS, 2019, 17 (06) : 5469 - 5480
12345